bluebird bio (BLUE) EHA a 'Solid Win', But Zynteglo’s Launch in EU Delayed - Cowen
Tweet Send to a Friend
Cowen analyst Yaron Werber reiterated an Outperform rating and {REMOVEPT} price target on bluebird bio (NASDAQ: BLUE)Werber commented, "At EHA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
